Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa

BMC Biochemistry

Volumn 8, Issue , 2007, Pages

  Westwood, Isaac M ^a   Sim, Edith ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ARYLAMINE ACETYLTRANSFERASE; BACTERIAL ENZYME; MESALAZINE; ENZYME INHIBITOR;

ACETYLATION; ARTICLE; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; STRUCTURE ANALYSIS; DRUG ANTAGONISM; ENZYMOLOGY; KINETICS; METABOLISM;

BACTERIA (MICROORGANISMS); EUKARYOTA; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA; PSEUDOMONAS AERUGINOSA;

ACETYL COENZYME A; ARYLAMINE N-ACETYLTRANSFERASE; ENZYME INHIBITORS; KINETICS; MESALAMINE; PSEUDOMONAS AERUGINOSA;

EID: 34147171051     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-8-3     Document Type: Article

References (46)

1. Involvement of Cys69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium. Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms. M Watanabe T Sofuni T Nohmi, J Biol Chem 1992 267 8429 8436 1569093
2. Lessons from the rifamycin biosynthetic gene cluster. HG Floss TW Yu, Curr Opin Chem Biol 1999 3 592 597 10.1016/S1367-5931(99)00014-9 10508670
3. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. S Bhakta GS Besra AM Upton T Parish C Sholto-Douglas-Vernon KJC Gibson S Knutton S Gordon RP daSilva MC Anderton E Sim, J Exp Med 2004 199 1191 1199 10.1084/jem.20031956 15117974
4. Purification, characterization, and crystallization of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium. JC Sinclair R Delgoda ME Noble S Jarmin NK Goh E Sim, Protein Expr Purif 1998 12 371 380 10.1006/prep.1997.0856 9535705
5. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. M Payton R Auty R Delgoda M Everett E Sim, J Bacteriol 1999 181 1343 1347 9973365
6. Structure of Mesorhizobium loti arylamine N-acetyltransferase 1. SJ Holton J Dairou J Sandy F Rodrigues-Lima JM Dupret M Noble E Sim, Acta Crystallograph Sect F Struct Biol Cryst Commun 2005 61 14 16 10.1107/S1744309104030659 16508079
7. Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. IM Westwood SJ Holton F Rodrigues-Lima JM Dupret S Bhakta ME Noble E Sim, Biochem J 2005 385 605 612 15447630 10.1042/BJ20041330
8. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis - an enzyme which inactivates the anti-tubercular drug, isoniazid. J Sandy A Mushtaq A Kawamura J Sinclair E Sim M Noble, J Mol Biol 2002 318 1071 1083 10.1016/S0022-2836(02)00141-9 12054803
9. Structure of arylamine N-acetyltransferase reveals a catalytic triad. JC Sinclair J Sandy R Delgoda E Sim ME Noble, Nat Struct Biol 2000 7 560 564 10.1038/76783 10876241
10. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines. J Sandy A Mushtaq SJ Holton P Schartau ME Noble E Sim, Biochem J 2005 390 115 123 15869465 10.1042/BJ20050277
11. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases. EW Brooke SG Davies AW Mulvaney F Pompeo E Sim RJ Vickers, Bioorg Med Chem 2003 11 1227 1234 10.1016/S0968-0896(02)00642-9 12628650
12. Reassessment of Ellman's reagent. PW Riddles RL Blakeley B Zerner, Methods Enzymol 1983 91 49 60 6855597
13. Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs). EW Brooke SG Davies AW Mulvaney M Okada F Pompeo E Sim RJ Vickers IM Westwood, Bioorg Med Chem Lett 2003 13 2527 2530 10.1016/S0960-894X(03)00484-0 12852958
14. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. DW Hein, Mutat Res 2002 506-507 65 77 12351146
15. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. FF Kadlubar AF Badawi, Toxicol Lett 1995 82-83 627 632 10.1016/0378-4274(95)03507-9 8597119
16. N-acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. PE Hanna, Adv Pharmacol 1994 27 401 430 8068562
17. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. RF Minchin, Biochem J 1995 307 1 3 7717963
18. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity. N Zhang L Liu F Liu CR Wagner PE Hanna KJ Walters, J Mol Biol 2006 363 188 200 10.1016/j.jmb.2006.08. 026 16959263
19. Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. F Rodrigues-Lima C Delomenie GH Goodfellow DM Grant JM Dupret, Biochem J 2001 356 327 334 11368758 10.1042/0264-6021:3560327
20. 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop. F Rodrigues-Lima JM Dupret, Biochem Biophys Res Commun 2002 291 116 123 10.1006/bbrc.2002.6414 11829470
21. Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening. A Kawamura J Graham A Mushtaq SA Tsiftsoglou GM Vath PE Hanna CR Wagner E Sim, Biochem Pharmacol 2005 69 347 359 10.1016/j.bcp.2004.09.014 15627487
22. Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. M Payton A Mushtaq TW Yu LJ Wu J Sinclair E Sim, Microbiology 2001 147 1137 1147 11320117
23. Acetyl-coenzyme A: arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate. B Riddle WP Jencks, J Biol Chem 1971 246 3250 3258 5103348
24. New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a variety of arylamines. HH Andres AJ Klem SM Szabo WW Weber, Anal Biochem 1985 145 367 375 10.1016/0003-2697(85)90376-8 4014668
25. Kinetic characteristics of the acetylation of isoniazid and p-aminosalicylic acid by a liver-enzyme preparation. JW Jenne PD Boyer, Biochim Biophys Acta 1962 65 121 127 10.1016/0006-3002(62)90155-5 14029035
26. N-acetylation of drugs: isolation and properties of an N-acetyltransferase from rabbit liver. WW Weber SN Cohen, Mol Pharmacol 1967 3 266 273 6037685
27. The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations. WW Cleland, Biochim Biophys Acta 1963 67 104 137 10.1016/0006-3002(63)91800-6 14021667
28. On the active site of liver acetyl-CoA. Arylamine N-acetyltransferase from rapid acetylator rabbits (III/J). HH Andres AJ Klem LM Schopfer JK Harrison WW Weber, J Biol Chem 1988 263 7521 7527 2897358
29. Characterization of the active site, substrate specificity and kinetic properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver. HH Andres HJ Kolb RJ Schreiber L Weiss, Biochim Biophys Acta 1983 746 193 201 6882770
30. Purification, physicochemical, and kinetic properties of liver acetyl-CoA:arylamine N-acetyltransferase from rapid acetylator rabbits. HH Andres RS Vogel GE Tarr L Johnson WW Weber, Mol Pharmacol 1987 31 446 456 3574290
31. Partial purification and properties of the isoniazid transacetylase in human liver: its relationship to the acetylation of p-aminosalicylic acid. JW Jenne, J Clin Invest 1965 44 1992 2002 5851956
32. Acetyl Coenzyme A : Arylamine Acetyltransferase (Measurement of the steady state concentration of the acetyl-enzyme intermediate). WP Jencks M Gresser MS Valenzuela FC Huneeus, J Biol Chem 1972 247 3756 3760 5064220
33. Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. D Hickman JR Palamanda JD Unadkat E Sim, Biochem Pharmacol 1995 50 697 703 10.1016/0006-2952(95)00182-Y 7669073
34. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies. H Wang GM Vath KJ Gleason PE Hanna CR Wagner, Biochemistry 2004 43 8234 8246 10.1021/bi0497244 15209520
35. Catalytic mechanism of hamster arylamine N-acetyltransferase 2. H Wang L Liu PE Hanna CR Wagner, Biochemistry 2005 44 11295 306 10.1021/bi047564q 16101314
36. A normalized plot as a novel and time-saving tool in complex enzyme kinetic analysis. IG Bravo F Busto D De Arriaga MA Ferrero LB Rodriguez-Aparicio H Martinez-Blanco A Reglero, Biochem J 2001 358 573 583 11577687
37. Regression analysis, experimental error, and statistical criteria in the design and analysis of experiments for discrimination between rival kinetic models. B Mannervik, Methods Enzymol 1982 87 370 390 7176922
38. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity. A Mushtaq M Payton E Sim, J Biol Chem 2002 277 12175 12181 10.1074/jbc.M104365200 11799105
39. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis. J Sandy S Holton E Fullam E Sim M Noble, Protein Sci 2005 14 775 782 10.1110/ps.041163505 15722451
40. NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium. R Delgoda LY Lian J Sandy E Sim, Biochim Biophys Acta 2003 1620 8 14 12595067
41. A Study of Arylamine N-acetyltransferase from Salmonella typhimurium. R Delgoda, D Phil Thesis Oxford, University of Oxford 1999
42. Structure and mechanism of arylamine N-acetyltransferases. IM Westwood A Kawamura E Fullam AJ Russell SG Davies E Sim, Curr Top Med Chem 2006 6 1641 1654 10.2174/156802606778108979 16918475
43. Expasy ProtParam tool. http://us.expasy.org/tools/protparam.html
44. Protein Identification and Analysis Tools on the ExPASy Server. E Gasteiger C Hoogland A Gattiker A Duvaud M Wilkins RD Appel A Bairoch, The Proteomics Protocols Handbook Totowa, Humana Press, Walker JM, 2005 571 607
45. KyPlot v2.0 beta 13. http://www.woundedmoon.org/win32/kyplot.html
46. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. N Guex MC Peitsch, Electrophoresis 1997 18 2714 2723 10.1002/elps.1150181505 9504803